Evaluation of Bone Mineral Density among elderly Type II Diabetes Mellitus Patients in Babil 2025
DOI:
https://doi.org/10.48165/aabr.2025.2.1.02Keywords:
Type 2 diabetes mellitus, Bone mineral density, Osteoporosis, DEXA scanAbstract
Background: Type 2 diabetes mellitus is associated with various complications, including potential impacts on bone health. Although elderly patients with Type 2 diabetes mellitus may exhibit normal bone mineral density they are paradoxically at a higher risk for fractures. The underlying mechanisms remain multifactorial, involving glycaemic control, hormonal regulation, and nutrient deficiencies. Objective: To evaluate bone mineral density in elderly patients with Type 2 diabetes mellitus and investigate its relationship with glycaemic control, vitamin D levels, and calcium status.Patients and Methods: A prospective, cross-sectional study was conducted on 46 patients above 65 years of age in Merjan teaching hospital babil, Iraq, from May 2024 to May 2025. Data collected included demographics, HbA1c levels, serum vitamin D and calcium, and bone mineral density measured via DEXA scans at the spine and hips. Results: Osteoporosis was present in 54.3% of patients, with 34.8% of patients were classified as osteopenic. The majority of patients were females. A positive correlation was found between HbA1c and DEXA scan T-scores (r = 0.313, p = 0.034), patients with poor glycaemic control (mean HbA1c = 9.2%) had a higher prevalence of osteoporosis. No significant correlations were found between bone mineral density (Dexa T-scores) and serum vitamin D (r = -0.057, p = 0.705) or calcium levels (r = -0.080, p = 0.597). The right hip showed the highest site-specific prevalence of osteoporosis (41.3%).Conclusions: Osteoporosis is highly prevalent among elderly patients, particularly women. Poor glycemic control (high HbA1c) and increasing age are significantly associated with lower bone density. Recommendation: DEXA scans of multiple sites, especially the spine and hips, are essential for detecting osteoporosis in this population.
References
1. Vianna AG, Sanches CP, Barreto FC. Effects of type 2 diabetes therapies on bone metabolism. Diabetol Metab Syndr. 2017;9:1.
2. Murray CE, Coleman CM. Impact of diabetes mellitus on bone health. Int J Mol Sci. 2019;20(19):4873.
3. Marin C, Luyten FP, Van der Schueren B, Kerckhofs G, Vandamme K. The impact of type 2 diabetes on bone fracture healing. Front Endocrinol (Lausanne). 2018;9:6.
4. Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep. 2015;13:327–335.
5. Jain RK, Vokes T. Dual-energy X-ray absorptiometry. J Clin Densitom. 2017;20(3):291–303.
6. Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019;8(3):R55–R70.
7. Kupai K, Kang HL, Pósa A, et al. Bone loss in diabetes mellitus: diaporosis. Int J Mol Sci. 2024;25(13):7269.
8. Sarodnik C, Bours SP, Schaper NC, Van den Bergh JP, Van Geel TA. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70–77.
9. Forner P, Sheu A. Bone health in patients with type 2 diabetes. J Endocr Soc. 2024;8(7):bvae112.
10. Fayyadh et al. Evaluation of bone mineral density among elderly type II diabetes mellitus patients in Babil. 2025.
11. Morrison S, Colberg SR, Mariano M, Parson HK, Vinik AI. Balance training reduces falls risk in older individuals with type 2 diabetes. Diabetes Care. 2010;33(4):748–750.
12. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Technical Report Series. 1994;843:1–129.
13. Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis. Curr Diab Rep. 2013;13:411–418.
14. Yuhao S, Cenyi W, Yang G, Guihua X, Yong M. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis. Iran J Public Health. 2019;48(7):1203.
15. Strotmeyer ES, Cauley JA, Schwartz AV, et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: the Health, Aging, and Body Composition Study. J Bone Miner Res. 2004;19(7):1084–1091.
16. Parizad N, Baghi V, Karimi EB, Gheshlagh RG. The prevalence of osteoporosis among Iranian postmenopausal women with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(4):2607–2612.
17. Linde J, De Vries F, De Bruin M, Vestergaard P. BMD decreases with increasing HbA1C levels: a cross-sectional study. Osteoporos Int. 2012;23:129.
18. Gao L, Liu Y, Li M, Wang Y, Zhang W. Based on HbA1c analysis: bone mineral density and osteoporosis risk in postmenopausal female with T2DM. J Clin Densitom. 2024;27(1):101442.
19. Cândido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014;15(4):6569–6591.
20. Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49:863–871.
21. Liu X, Chen F, Liu L, Zhang Q. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr Disord. 2023;23(1):1.
